Photoradiation Therapy of Bladder Tumors
- 1 October 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 130 (4) , 685-687
- https://doi.org/10.1016/s0022-5347(17)51403-2
Abstract
Photoradiation therapy, in which hematoporphyrin derivative is activated by an argon-dye laser, was performed on 46 sueprficial bladder tumors in 9 patients. A fluorospectrophotometric study of biopsies from these tumors and normal mucosa revealed preferential hematoporphyrin derivative localization in malignant tissues. The tumor response was confirmed ultrasonographically in 36 stages Ta to Tl tumors. Treatment with 100-250 J/cm2 obtained complete remission in 5 of 6 patients with tumors .ltoreq. 1 cm in size. For those with tumors up to 2 cm in size the light intensity should be 300 mW/cm2 for 5-10 min or more and the accumulated energy intensity of light dose should be .gtoreq. 100 J/cm2. No patient with tumors more than 2 cm in size had a complete remission.This publication has 7 references indexed in Scilit:
- TYPE I AND TYPE II MECHANISMS IN THE PHOTOSENSITIZED LYSIS OF PHOSPHATIDYLCHOLINE LIPOSOMES BY HEMATOPORPHYRINPhotochemistry and Photobiology, 1982
- Hematoporphyrin Derivative and Laser Photoradiation in the Treatment of Lung CancerChest, 1982
- Hematoporphyrin Derivative: A Possible Aid in the Diagnosis and Therapy of Carcinoma of the BladderJournal of Urology, 1976
- Photodynamic destruction of human bladder carcinomaBritish Journal of Cancer, 1975
- Hematoporphyrin-Derivative Fluorescence in Malignant NeoplasmsAnnals of Surgery, 1968
- Further Evaluation of the Use of Hematoporphyrin Derivative As a New Aid for the Endoscopic Detection of Malignant Disease* *From the Mayo Clinic and Mayo Foundation. This investigation was supported in part by Research Grant ASP-9880 from the National Institutes of Health, Public Health Service.Diseases of the Chest, 1964
- HEMATOPORPHYRIN DERIVATIVE FOR DETECTION OF CERVICAL CANCER1964